Chorea-acanthocytosis is primarily a neurological disorder that affects movement in many parts of the body. Chorea refers to the involuntary jerking movements made by people with this disorder.
People with this condition also have abnormal star-shaped red blood cells (acanthocytosis). This condition is one of a group of conditions called neuroacanthocytoses that involve neurological problems and abnormal red blood cells.
In addition to chorea, another common feature of chorea-acanthocytosis is involuntary tensing of various muscles (dystonia), such as those in the limbs, face, mouth, tongue, and throat. These muscle twitches can cause vocal tics (such as grunting), involuntary belching, and limb spasms. Eating can also be impaired as tongue and throat twitches can interfere with chewing and swallowing food. People with chorea-acanthocytosis may uncontrollably bite their tongue, lips, and inside of the mouth. Nearly half of all people with chorea-acanthocytosis have seizures.
Individuals with chorea-acanthocytosis may develop difficulty processing, learning, and remembering information (cognitive impairment). They may have reduced sensation and weakness in their arms and legs (peripheral neuropathy) and muscle weakness (myopathy). Impaired muscle and nerve functioning commonly cause speech difficulties in individuals with this condition, and can lead to an inability to speak.
Behavioral changes are a common feature of chorea-acanthocytosis and may be the first sign of this condition. These behavioral changes may include changes in personality, obsessive-compulsive disorder (OCD), lack of self-restraint, and the inability to take care of oneself.
The signs and symptoms of chorea-acanthocytosis usually begin in early to mid-adulthood. The movement problems of this condition worsen with age. Loss of cells (atrophy) in certain brain regions is the major cause of the neurological problems seen in people with chorea-acanthocytosis.
It is estimated that 500 to 1,000 people worldwide have chorea-acanthocytosis.
Mutations in the VPS13A gene cause chorea-acanthocytosis. The VPS13A gene provides instructions for producing a protein called chorein; the function of this protein in the body is unknown. Some researchers believe that chorein plays a role in the movement of proteins within cells. Most VPS13A gene mutations lead to the production of an abnormally small, nonfunctional version of chorein. The VPS13A gene is active (expressed) throughout the body; it is unclear why mutations in this gene affect only the brain and red blood cells.
This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.
5. Other Names for This Condition
The entry is from https://medlineplus.gov/genetics/condition/chorea-acanthocytosis
- Benninger F, Afawi Z, Korczyn AD, Oliver KL, Pendziwiat M, Nakamura M, Sano A,Helbig I, Berkovic SF, Blatt I. Seizures as presenting and prominent symptom inchorea-acanthocytosis with c.2343del VPS13A gene mutation. Epilepsia. 2016Apr;57(4):549-56. doi: 10.1111/epi.13318.
- Connolly BS, Hazrati LN, Lang AE. Neuropathological findings inchorea-acanthocytosis: new insights into mechanisms underlying parkinsonism andseizures. Acta Neuropathol. 2014 Apr;127(4):613-5. doi:10.1007/s00401-013-1241-3.
- Dobson-Stone C, Danek A, Rampoldi L, Hardie RJ, Chalmers RM, Wood NW, Bohlega S, Dotti MT, Federico A, Shizuka M, Tanaka M, Watanabe M, Ikeda Y, Brin M,Goldfarb LG, Karp BI, Mohiddin S, Fananapazir L, Storch A, Fryer AE, Maddison P, Sibon I, Trevisol-Bittencourt PC, Singer C, Caballero IR, Aasly JO, Schmierer K, Dengler R, Hiersemenzel LP, Zeviani M, Meiner V, Lossos A, Johnson S, Mercado FC,Sorrentino G, Dupré N, Rouleau GA, Volkmann J, Arpa J, Lees A, Geraud G,Chouinard S, Németh A, Monaco AP. Mutational spectrum of the CHAC gene inpatients with chorea-acanthocytosis. Eur J Hum Genet. 2002 Nov;10(11):773-81.
- Dobson-Stone C, Velayos-Baeza A, Jansen A, Andermann F, Dubeau F, Robert F,Summers A, Lang AE, Chouinard S, Danek A, Andermann E, Monaco AP. Identification of a VPS13A founder mutation in French Canadian families withchorea-acanthocytosis. Neurogenetics. 2005 Sep;6(3):151-8.
- Karkheiran S, Bader B, Roohani M, Danek A, Shahidi GA. Chorea-acanthocytosis: report of three cases from Iran. Arch Iran Med. 2012 Dec;15(12):780-2. doi:0121512/AIM.0013.
- Rampoldi L, Dobson-Stone C, Rubio JP, Danek A, Chalmers RM, Wood NW, Verellen C, Ferrer X, Malandrini A, Fabrizi GM, Brown R, Vance J, Pericak-Vance M, Rudolf G, Carrè S, Alonso E, Manfredi M, Németh AH, Monaco AP. A conservedsorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet. 2001Jun;28(2):119-20.
- Ueno S, Maruki Y, Nakamura M, Tomemori Y, Kamae K, Tanabe H, Yamashita Y,Matsuda S, Kaneko S, Sano A. The gene encoding a newly discovered protein,chorein, is mutated in chorea-acanthocytosis. Nat Genet. 2001 Jun;28(2):121-2.
- Walker RH, Jung HH, Dobson-Stone C, Rampoldi L, Sano A, Tison F, Danek A.Neurologic phenotypes associated with acanthocytosis. Neurology. 2007 Jan9;68(2):92-8. Review.